Regular treatments of praziquantel do not impact on the genetic make-up of Schistosoma mansoni in Northern Senegal

Infection, Genetics and Evolution

Volumn 18, Issue , 2013, Pages 100-105

  Huyse, T ^a,b   Van den Broeck, F ^a,b   Jombart, T ^c   Webster, B L ^d,e   Diaw, O ^f   Volckaert, F A M ^a   Balloux, F ^g   Rollinson, D ^d   Polman, K ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d DEPARTMENT OF LIFE SCIENCES   (United Kingdom)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f Institut Senegalais de Recherches AgrEcoles Dakar   (Senegal)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cure rates; Drug resistance; Molecular epidemiology; Praziquantel; Schistosomiasis; Transmission

Indexed keywords

MICROSATELLITE DNA; PRAZIQUANTEL;

ADOLESCENT; ARTICLE; CHILD; DISEASE TRANSMISSION; DRUG RESISTANCE; GENE LOCUS; GENETIC STRAIN; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTESTINE INFECTION; MIRACIDIUM; PRESCHOOL CHILD; PRIORITY JOURNAL; REINFECTION; SCHISTOSOMIASIS HAEMATOBIA; SCHISTOSOMIASIS MANSONI; SCHOOL CHILD; SENEGAL; TREATMENT DURATION;

CURE RATES; DRUG RESISTANCE; MOLECULAR EPIDEMIOLOGY; PRAZIQUANTEL; SCHISTOSOMIASIS; TRANSMISSION;

ANIMALS; ANTHELMINTICS; CLUSTER ANALYSIS; DRUG RESISTANCE; FECES; GENETIC VARIATION; GENOTYPE; HUMANS; MOLECULAR EPIDEMIOLOGY; PRAZIQUANTEL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SENEGAL;

SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMA MANSONI;

EID: 84879368335     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2013.05.007     Document Type: Article

References (40)

1. Balloux F. Heterozygote excess in small populations and the heterozygote-excess effective population size. Evolution 2004, 58:1891-1900.
2. Coles G.C. Drug resistance and drug tolerance in parasites. Trends Parasitol. 2006, 22:348.
3. Cornuet J.M., Luikart G. Description and power analysis of two tests for detecting recent population bottlenecks from allele frequency data. Genetics 1996, 144:2001-2014.
4. Danso-Appiah A., De Vlas S.J. Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal. Trends Parasitol. 2002, 18:125-129.
5. De Clercq D., Vercruysse J., Picquet M., Shaw D.J., Diop M., Ly A., Gryseels B. The epidemiology of a recent focus of mixed Schistoroma haematobium and Schistosoma mansoni infections around the 'Lac de Guiers' in the Senegal River Basin, Senegal. Trop. Med. Int. Health 1999, 4:544-550.
6. Doenhoff M.J., Kusel J.R., Coles G.C., Cioli D. Resistance of Schistosoma mansoni to praziquantel: is there a problem?. Trans. R. Soc. Trop. Med. Hyg. 2002, 96:465-469.
7. Ernould J.C., Ba K., Sellin B. Increase of intestinal schistosomiasis after praziquantel treatment in a Schistosoma haematobium and Schistosoma mansoni mixed focus. Acta Trop. 1999, 73:143-152.
8. Fallon P.G., Hamilton J.V., Doenhoff M.J. Efficacy of treatment of murine Schistosoma mansoni infections with praziquantel and oxamniquine correlates with infection intensity - role of host antibody. Parasitology 1995, 111:59-66.
9. Fallon P.G., Mubarak J.S., Fookes R.E., Niang M., Butterworth A.E., Sturrock R.F., Doenhoff M.J. Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates. Exp. Parasitol. 1997, 86:29-36.
10. Goudet, J., 2001. FSTAT, a program to estimate and test gene diversities and fixation indices (version 2.9.3). http://www.unil.ch/izea/softwares/fstat.html.
11. Gryseels B., Stelma F.F., Talla I., Vandam G.J., Polman K., Sow S., Diaw M., Sturrock R.F., Doehringschwerdtfeger E., Kardorff R., Decam C., Niang M., Deelder A.M. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal. Trop. Geogr. Med. 1994, 46:209-219.
12. Gryseels B., Mbaye A., De Vlas S.J., Stelma F.F., Guisse F., Van Lieshout L., Faye D., Diop M., Ly A., Tchuem-Tchuente L.A., Engels D., Polman K. Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence. Trop. Med. Int. Health 2001, 6:864-873.
13. Gryseels B., Polman K., Clerinx J., Kestens L. Human schistosomiasis. Lancet 2006, 368:1106-1118.
14. Hotez P.J., Kamath A. Neglected tropical diseases in sub-Saharan Africa: review of their prevalence, distribution, and disease burden. Plos Negl. Trop. Dis. 2009, 3:e412.
15. Huyse T., Webster B.L., Geldof S., Stothard J.R., Diaw O.T., Polman K., Rollinson D. Bidirectional introgressive hybridization between a cattle and human schistosome species. PLoS Pathog. 2009, 5:e1000571.
16. Jombart T. Adegenet: a R package for the multivariate analysis of genetic markers. Bioinformatics 2008, 24:1403-1405.
17. Jombart T., Devillard S., Balloux F. Discriminant analysis of principal components: a new method for the analysis of genetically structured populations. BMC Genet. 2010, 11:94.
18. Katz N., Chavez A., Pellegrino J. A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev. I. Med. Trop. 1972, 14:397-400.
19. King C.H., Olbrych S.K., Soon M., Singer M.E., Carter J., Colley D.G. Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review. Plos. Neg. Trop. Dis. 2011, 5:e1321.
20. Meurs L., Mbow M., Vereecken K., Menten J., Mboup S., Polman K. Epidemiology of mixed Schistosoma mansoni and Schistosoma haematobium infections in Northern Senegal. Int. J. Parasitol. 2012, 42:305-311.
21. Montresor A. Cure rate is not a valid indicator for assessing drug efficacy and impact of preventive chemotherapy interventions against schistosomiasis and soil-transmitted helminthiasis. Trans. R. Soc. Trop. Med. Hyg. 2011, 105:361-363.
22. Norton A.J., Gower C.M., Lamberton P.H.L., Webster B.L., Lwambo N.J.S., Blair L., Fenwick A., Webster J.P. Genetic consequences of mass human chemotherapy for Schistosoma mansoni: population structure pre- and post-praziquantel treatment in Tanzania. Am. J. Trop. Med. Hyg. 2010, 83:951-957.
23. Picquet M., Ernould J.C., Vercruysse J., Southgate V.R., Mbaye A., Sambou B., Niang M., Rollinson D. The epidemiology of human schistosomiasis in the Senegal river basin. T. Roy. Soc. Trop. Med. H. 1996, 90:340-346.
24. Picquet M., Vercruysse J., Shaw D.J., Diop M., Ly A. Efficacy of praziquantel against Schistosoma mansoni in northern Senegal. T. Roy. Soc. Trop. Med. H. 1998, 92:90-93.
25. Pitchford R.J., Visser P.S. Simple and rapid technique for quantitative estimation of helminth eggs in human and animal excreta with special reference to Schistosoma sp. T. Roy. Soc. Trop. Med. H. 1975, 69:318-322.
26. Polman K., Stelma F.F., le Cessie S., de Vlas S.J., Ferreira S., Talla I., Deelder A.M., Gryseels B. Evaluation of the patterns of Schistosoma mansoni infection and re-infection in Senegal, from faecal egg counts and serum concentrations of circulating anodic antigen. Ann. Trop. Med. Parasitol. 2002, 96:679-689.
27. Prugnolle F., Roze D., Theron A., DE Meeus T. F-statistics under alternation of sexual and asexual reproduction: a model and data from schistosomes (platyhelminth parasites). Mol. Ecol. 2005, 14:1355-1365.
28. R Development Core Team R: A Language and Environment for Statistical Computing 2011, R Foundation for Statistical Computing, Vienna, Austria.
29. Renganathan E., Cioli D. An international initiative on praziquantel use. Parasitol. Today 1998, 14:390-391.
30. Sabah A.A., Fletcher C., Webbe G., Doenhoff M.J. Schistosoma mansoni - chemotherapy of infections of different ages. Exp. Parasitol. 1986, 61:294-303.
31. Savioli L., Albonico M., Engels D., Montresor A. Progress in the prevention and control of schistosomiasis and soil-transmitted helminthiasis. Parasitol. Int. 2004, 53:103-113.
32. Southgate V.R., Jourdane J., Tchuente L.A.T. Recent studies on the reproductive biology of the schistosomes and their relevance to speciation in the Digenea. Int. J. Parasitol. 1998, 28:1159-1172.
33. Stelma F.F., Talla I., Sow S., Kongs A., Niang M., Polman K., Deelder A.M., Gryseels B. Efficacy and side-effects of praziquantel in an epidemic focus of Schistosoma mansoni. Am. J. Trop. Med. Hyg. 1995, 53:167-170.
34. Talla I., Kongs A., Verle P., Belot J., Sarr S., Coll A.M. Outbreak of intestinal schistosomiasis in the Senegal River Basin. Ann. Soc. Belg. Med. Tr. 1990, 70:173-180.
35. Van den Broeck F., Geldof S., Polman K., Volckaert F.A.M., Huyse T. Optimal sample storage and extraction procotols for reliable multilocus genotyping of the human parasite Schistosoma mansoni. Infect. Genet. Evol. 2011, 11:1413-1418.
36. Van Oosterhout C., Hutchinson W.F., Wills D.P.M., Shipley P. MICRO-CHECKER: software for identifying and correcting genotyping errors in microsatellite data. Mol. Ecol. Notes 2004, 4:535-538.
37. Verle P., Stelma F., Desreumaux P., Dieng A., Diaw O., Kongs A., Niang M., Sow S., Talla I., Sturrock R.F., Gryseels B., Capron A. Preliminary study of urinary schistosomiasis in a village in the delta of the Senegal River Basin, Senegal. T. Roy. Soc. Trop. Med. H. 1994, 88:401-405.
38. Webster B.L., Southgate V.R., Tchuente L.A.T. Mating interactions between Schistosoma haematobium and S. mansoni. J. Helminthol. 1999, 73:351-356.
39. Webster, B.L., Diaw, O.T., Seye, M.M., Faye, D.S., Stothard, J.R., Figueiredo, J.C.S., Rollinson, D., in press. Impact of praziquantel treatment on human schistosomiasis in Senegal River Basin: monitoring the efficacy of cure and re-infection patterns at mixed (Schistosoma mansoni & S. haematobium) and single (S. haematobium) infection foci. Acta Trop.
40. Weir B.S., Cockerham C.C. Estimating F-statistics for the analysis of population-structure. Evolution 1984, 38:1358-1370.